西安地区体检人群动脉粥样硬化性心血管疾病发病风险和风险因素研究

doi:10.12183/j.scjpm.2022.0700

[1] 中国心血管健康与疾病报告编写组. 《中国心血管健康与疾病报告 2019》要点解读[J].中国心血管杂志,2020,25(5):401-410.
[2] 刘艳,曾高峰. 骨标志物水平与2型糖尿病患者心血管疾病风险研究[J].中南医学科学杂志,2020,48(4):356-359.
[3] 吴超群,李希,路甲鹏,等. 中国居民心血管疾病危险因素分布报告[J].中国循环杂志,2021,36(1):4-13.
[4] D＇Agostino RB Sr,Vasan RS,Pencina MJ,et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study[J].Circulation,2008,117(6):743-753.
[5] Piepoli MF, Hoes AW, Agewall S, et al.ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention ＆ Rehabilitation (EACPR)[J].Eur Heart J,2016,37(29):2315-2381.
[6] Hippisley-Cox J,Coupland C,Vinogradova Y,et al.Derivation and validation of QRISK,a new cardiovascular disease risk score for the United Kingdom: Prospective open cohort study[J].BMJ, 2007, 335(7611):136.
[7] Arnett DK,Blumenthal RS,Albert MA,et al.2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J].Circulation,2019,140(11):e596-e646.
[8] Yang X,Li J,Hu DS,et al.Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: The China-PAR Project(Prediction for ASCVD Risk in China)[J].Circulation,2016,134(19):1430-1440.
[9] 中国心血管病风险评估和管理指南编写联合委员会. 中国心血管病风险评估和管理指南[J].中华预防医学杂志,2019, 53(1):13-35.
[10] 沈德蕾, 陈浩, 赵超,等. 上海市徐汇区45~55岁居民动脉粥样硬化性心血管疾病风险的影响因素分析[J].中国全科医学, 2020, 23(6):716-720.
[11] 程淇, 黄雨晴, 冯颖青. 非空腹血脂与动脉粥样硬化性心血管疾病发生及预后关系的研究进展[J].中华老年多器官疾病杂志, 2021, 20(11):866-870.
[12] 中华预防医学会,中华预防医学会心脏病预防与控制专业委员会,中华医学会糖尿病学分会,等. 中国健康生活方式预防心血管代谢疾病指南[J].中国循环杂志,2020,35(3) :209-230.
[13] 代华杰,榻立平,项家丽,等. 上海市社区中老年人群健康的血管衰老和心血管疾病患病风险的相关性研究[J].上海交通大学学报(医学版),2021,41(2):223-227.
[14] 中国心血管病风险评估和管理指南编写联合委员会. 中国心血管病风险评估和管理指南[J].中国循环杂志,2019,34(1):4-28.
[15] 左惠娟,杨红霞,南楠,等. 中国初发急性心肌梗死的青年患者ASCVD传统危险因素与美国相关研究结果的差异分析[J].中华心血管病杂志,2021,49(6):580-585.
[16] Yang XL, Chen JC, Li JX, et al.Risk stratification of atherosclerotic cardiovascular disease in Chinese adults[J].Chronic Dis Transl Med,2016,2(2):102-109.
[17] Li X,Wu C,Lu JP,et al.Cardiovascular risk factors in China: A nationwide population-based cohort study[J].Lancet Public Health,2020,5(12):e672-e681.

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	YAN Chun, GONG Yuan, HUANG Ping, CHEN Juan, HUANG Miao. Early poor prognosis and predictive model construction in patients with acute ischemic stroke [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1213-1217.
[2]	XU Yan, WANG Xuexia, HAN Chunling. Characteristics and influencing factors of polypoid lesion of gallbladder in adult residents of Dongying City [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1224-1228.
[3]	. [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1294-1297.
[4]	. [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1305-1308.
[5]	. [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1327-1329.
[6]	JING Leilei, WANG Yating, YANG Yong, LI Yajie, ZHAO Haiying, LI Huifang, LI Zhanpeng. Influencing factors of knee osteoarthritis in people ≥ 40 years old in Zhangjiakou area [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1078-1082.
[7]	WANG Shijian, CHEN Zelun, ZHENG Jingjing, XU Ying. Analysis of the incidence and influencing factors of retinopathy in elderly patients with hypertension [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1098-1102.
[8]	ZHAO Xiaohong, XU Shanshan, HAN Yuzhou, HUANG Haisha, SUN Jingjing. Status and influencing factors of adverse pregnancy outcomes in pregnant women with gestational diabetes mellitus in Langfang City [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1109-1113.
[9]	LI Nannan, HUANG Limin, ZHANG Xiaohua. Incidence and risk factors of major adverse cardiovascular events in patients with acute coronary syndrome within 1 year after discharge [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1119-1123.
[10]	. [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1180-1183.
[11]	. [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1188-1191.
[12]	. [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1205-1208.
[13]	YAN Yongfeng, XU Yuanyou, WANG Jun, CHEN Yongsheng, ZHANG Yonghui, DING Lulu, CHEN Jianguo, FAN Jian, ZHU Jian. Trend analysis of brain tumor survival rate in Qidong City, Jiangsu Province, 1972 - 2016 [J]. South China Journal of Preventive Medicine, 2023, 49(8): 960-964.
[14]	LUO Chengli, LIU Fangjing, PENG Xiang, LI Shimei, WU Qiaohui, MAO Li, DONG Yuan, SUN Xianfu, LI Shuangle. Prevalence and influencing factors of cataract among the elderly in Zigong City [J]. South China Journal of Preventive Medicine, 2023, 49(8): 990-994.
[15]	FAN Hailong, NIU Yanbin, GUO Zhenshan, AN Qianjiang, WANG Xiumei. Association between visceral adiposity index and blood glucose variation in Chinese middle-aged and elderly prediabetic population： a cohort study [J]. South China Journal of Preventive Medicine, 2023, 49(7): 803-807.